Supriya Lifescience's board approved the financial results for the quarter.

Supriya Lifescience LimitedSUPRIYA · Filed with the exchange

Revenue from operations reached ₹189.75 Cr, with net profit at ₹24.04 Cr (EPS ₹2.99). An export shipment was detained by Customs, but revenue was recognized.

Investors note operational resilience.

Read the original filing(PDF)

No comments yet. Be the first.

More from Supriya Lifescience Limited

All announcements

Investor Meet11-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Updates02-09-2026
General Updates
Updates02-09-2026
General Updates
Others02-09-2026
Copy of Newspaper Publication
Others01-09-2026
Shareholders meeting
Others27-08-2026
Copy of Newspaper Publication

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.